Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Work In Process (2019 - 2025)

Ptc Therapeutics has reported Work In Process over the past 7 years, most recently at $55.7 million for Q4 2025.

  • Quarterly results put Work In Process at $55.7 million for Q4 2025, up 355.84% from a year ago — trailing twelve months through Dec 2025 was $55.7 million (up 355.84% YoY), and the annual figure for FY2025 was $55.7 million, up 355.84%.
  • Work In Process for Q4 2025 was $55.7 million at Ptc Therapeutics, up from $41.8 million in the prior quarter.
  • Over the last five years, Work In Process for PTCT hit a ceiling of $55.7 million in Q4 2025 and a floor of $7.0 million in Q2 2022.
  • Median Work In Process over the past 5 years was $16.0 million (2022), compared with a mean of $18.4 million.
  • Peak annual rise in Work In Process hit 355.84% in 2025, while the deepest fall reached 41.09% in 2025.
  • Ptc Therapeutics' Work In Process stood at $7.7 million in 2021, then skyrocketed by 82.28% to $14.1 million in 2022, then increased by 27.83% to $18.0 million in 2023, then tumbled by 32.1% to $12.2 million in 2024, then surged by 355.84% to $55.7 million in 2025.
  • The last three reported values for Work In Process were $55.7 million (Q4 2025), $41.8 million (Q3 2025), and $24.4 million (Q2 2025) per Business Quant data.